Literature DB >> 1734223

Isolated breast relapse after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia.

V Conter1, P D'Angelo, A Rovelli, C Uderzo, M Jankovic, G Bratina, G Masera.   

Abstract

Unusual sites of relapses following bone marrow transplantation (BMT) for childhood acute lymphoblastic leukemia (ALL) are rarely reported. We report the case of a 16-year-old girl who presented with an isolated right breast relapse 8 months after allogeneic BMT for ALL in second remission. Biopsy showed an ALL infiltrate. Bone marrow and CSF were normal. The girl never showed before extramedullary involvement. She was treated with local radiotherapy and mild systemic chemotherapy. Nine months after breast relapse, she presented an isolated central nervous system relapse. The treatment of isolated extramedullary relapses following BMT is still controversial.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1734223     DOI: 10.1002/mpo.2950200214

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  3 in total

1.  Isolated extramedullary relapse of acute lymphoblastic leukemia in the breast of an adolescent girl: radiologic findings and discussion.

Authors:  Prasanna R G Kumar; Zachary Grossman; Lari Scorza; Thaer Khoury; Rahul Nayyar
Journal:  Pediatr Radiol       Date:  2010-02-05

Review 2.  Complete response of extramedullary relapse in breast of acute T lymphoblastic leukemia after bone marrow transplantation to chemoradiotherapy: a case report and literature review.

Authors:  Bailong Liu; Bin Liu; Xu Wang; Liang Guo; Xiaoliang Liu; Wei Han; Lihua Dong; Min Liu
Journal:  BMC Cancer       Date:  2016-11-09       Impact factor: 4.430

3.  Unusual isolated extramedullary relapse of acute lymphoblastic leukemia in the breast despite complete donor hematopoietic chimerism after allogeneic hematopoietic stem cell transplantation.

Authors:  Pack Hyun Sung; Changjo Im; Shin Young Hyun; Kwang Yong Shim; Jong In Lee; Jee Hyun Kong
Journal:  Korean J Intern Med       Date:  2017-11-10       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.